multiple pd-1/pd-l1 agents in lung cancer
Published 9 years ago • 442 plays • Length 5:57Download video MP4
Download video MP3
Similar videos
-
2:19
combining ctla-4 agents with pd-1/pd-l1 agents in lung cancer
-
7:22
pd-1 inhibition in lung cancer
-
1:15
dr. rizvi on pd-1 and pd-l1 inhibitors in lung cancer
-
1:02
dr. topalian on evolution of pd-1/pd-l1 agents in oncology
-
1:13
dr. herbst on targeting pd-1 and pd-l1 in lung cancer
-
4:25
pd-1/pd-l1 inhibitors explored across nsclc settings
-
6:10
pd-1 inhibitor use in advanced lung cancer
-
1:02
dr. herbst on pd-1 inhibitors in lung cancer
-
0:58
dr. chandra belani on selecting the best anti pd-l1 agent in lung cancer
-
1:57
targeting pd-1 and pd-l1 for lung cancer therapy
-
5:53
are pd-1/pd-l1 immune checkpoint inhibitors completely interchangeable in lung cancer? (bmic-015)
-
4:27
understanding immunotherapy for nsclc with pd-1 and pd-l1 biomarkers
-
2:03
dr. natale on the utility of pd-l1 and tmb in lung cancer
-
![anti-pd-1/pd-l1 antibodies in lung cancer - video abstract [id 55176]](https://i.ytimg.com/vi/9UUNnpNMpGE/mqdefault.jpg)
2:30
anti-pd-1/pd-l1 antibodies in lung cancer - video abstract [id 55176]
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
3:29
are there clinically significant distinctions between pd-1 and pd-l1?
-
4:52
targeting the immune system in non-small cell lung cancer
-
4:55
long-term outcomes with pd-1 monotherapy in nsclc